about
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein responseEndoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gammaCancer Microenvironment and Endoplasmic Reticulum Stress ResponseMechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cellsThe Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer TherapeuticsThe Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum StressAdipose tissue dysfunction and its effects on tumor metabolismTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesThe ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory groupMolecular carcinogenesis of canine mammary tumors: news from an old diseaseER chaperones in mammalian development and human diseasesRegulation of bone formation and remodeling by G-protein-coupled receptor 48The transcription factor XBP-1 is essential for the development and survival of dendritic cellsPlacental Origins of Chronic Disease.The role of the unfolded protein response in the heart.An RNA interference screen identifies a novel regulator of target of rapamycin that mediates hypoxia suppression of translation in Drosophila S2 cells.The role of HTS in drug discovery at the University of Michigan.Regulation of G(1) arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.Galectins and gliomas.The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput dataNew Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver DiseasesDrosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxiaNovel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.Increase in gene-transcript levels as indicators of up-regulation of the unfolded protein response in spontaneous canine tumors.ER stress, autophagy, and RNA viruses.Inhibition of mesothelin as a novel strategy for targeting cancer cells.MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1β.Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression.Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response.New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cellsProteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy.Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.Plant stilbenes induce endoplasmic reticulum stress and their anti-cancer activity can be enhanced by inhibitors of autophagyThe mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.Type I interferons mediate pancreatic toxicities of PERK inhibition.Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis.ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.
P2860
Q24292966-A66EB669-195B-479A-9D06-A41EA2A7811AQ24299225-D61E642A-FC0F-49D5-914C-D6BE62C769D4Q26778533-7EBC28A2-3A56-424B-8119-0B529A9A308CQ27014979-DCFC1F3E-84BA-44A3-A92C-CD53043619FDQ27026256-4E16225F-CF54-4DBA-A9FD-BEDDC56D8793Q28068986-B8EE703B-F889-42F1-908A-E5852B2BF75EQ28080748-C08B66C8-6054-4F90-B87B-403098E813A3Q28085631-C377309B-983B-4FFF-ADAD-A30A27595314Q28299691-50861B6C-D8AB-4BC2-AED6-F2F76FB7B90DQ28300581-EC6F0F6A-3A23-4BF2-AF87-00654B8C8DA8Q28300625-5F62FC8A-E0A3-475D-9304-AC2875A8CE95Q28507625-6FAEB92E-0E81-459C-ADA9-96E2831C390AQ28512302-F33A6DE1-0403-484E-8773-D0B73936692EQ30245567-84DD9BD1-5621-4DC2-9281-963849CB2484Q30366262-EDD0343F-E6BC-43B0-A2CE-E6F657583B86Q30483779-BF55E409-6A5D-4860-A6AE-EFDE0B8A0F3FQ31147980-4E42DAF1-FD4C-4C06-BD92-2A84B33600F8Q33588288-2EDFDB56-A899-46DA-B4BE-30C7B66F042CQ33588438-F74D5CE3-8F33-4051-AC3C-DF0E78CA6F60Q33592056-3A1A734B-ABB8-41C6-A649-4689FB781421Q33608283-D3BEA016-FC45-4097-8E2E-26C1AC6D6064Q33619194-4040E43E-B606-42B5-8611-0AD46A954EA4Q33720758-1375EB53-3E39-4F0F-8B5E-4AD24A26B544Q33763237-3E84E8E2-AAED-49BE-BDAE-DC30FA7B3E70Q33797761-CE733D0E-0C70-4DC9-BE61-187F5C70B6FEQ34003896-3D30BDFE-D1C8-40ED-B55D-2108B72AF48EQ34224746-330B28C6-771A-4A9F-9FA8-510731A4282CQ34336153-37A0EB3C-7A8B-4747-AC6C-2ED54E808A89Q34410183-273A896A-2FDC-44E1-B5A0-D2C8B9FEA9C6Q34508154-1F361A49-DE86-4CE9-BF53-8708A0519F64Q35016962-CA0BE3B7-4C5A-46B3-9A72-A9BACB8D1DA5Q35469778-0B8BA665-7547-4BC2-80D2-05C4A6BC7644Q35783230-97456F75-8FFE-4407-BC15-F31F83C83CFCQ35811795-5E604C8C-C542-4C03-9DF9-3623494F2B9FQ35876952-99CE523F-CC20-4ECD-ADD4-7E8CDD591F40Q36394344-4826AAC1-C899-439D-8AAE-9F6B9B036078Q36404060-447D7B82-C87A-4D5C-9511-75247F945175Q36435206-AC0C57A2-27F9-424A-AC0F-070F4CB2CFB0Q36497999-3EF9F502-48EB-4FE8-8259-03042AD2306EQ36544227-55EFBAD3-AE35-4775-AE64-8A5A24645A43
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
ER stress, hypoxia tolerance and tumor progression.
@ast
ER stress, hypoxia tolerance and tumor progression.
@en
type
label
ER stress, hypoxia tolerance and tumor progression.
@ast
ER stress, hypoxia tolerance and tumor progression.
@en
prefLabel
ER stress, hypoxia tolerance and tumor progression.
@ast
ER stress, hypoxia tolerance and tumor progression.
@en
P1476
ER stress, hypoxia tolerance and tumor progression
@en
P2093
Constantinos Koumenis
P356
10.2174/156652406775574604
P577
2006-02-01T00:00:00Z